glp-1 drug market news today obesity october 2025 GLP-1 Agonists Weight Loss Drugs Size Report, 2030 GLP-1 Drugs Drop More Than

Find Mounjaro and other health products at myAster online pharmacy Conclusion The surprising benefits of GLP-1 medications are no longer a footnote but a central part of their story

This category includes psyllium husk, beta-glucan from oats, pectin from fruits, and guar gum

As the dosage of the drug increased, the patients' weight continued to decrease, and this reduction was maintained for a significant duration after the last administration, lasting up to 150 days

Healthline Media does not provide medical advice, diagnosis, or treatment

( Epub 20150531 )

This shift could reflect a changing demand away from oncology toward addressing metabolic disorders. Leading the charge in the GLP1 market are five key drugs: Mounjaro, Ozempic, Wegovy, Cagrisema, and Rybelsus, which are forecast to capture 83 per cent of the GLP-1 agonist market by 2029